4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide

C40H45F2N11O7 — CID 167463013

IUPAC4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide
SMILESCOc1cc(C(=O)NN2CCC(N3CCN(c4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C2)ccc1Nc1ncc2c(n1)N(C(C)C)CC(F)(F)C(=O)N2C
InChIInChI=1S/C40H45F2N11O7/c1-22(2)52-21-40(41,42)38(59)48(3)29-19-43-39(46-33(29)52)44-26-9-8-23(18-30(26)60-4)34(55)47-51-13-12-24(20-51)49-14-16-50(17-15-49)27-7-5-6-25-32(27)37(58)53(36(25)57)28-10-11-31(54)45-35(28)56/h5-9,18-19,22,24,28H,10-17,20-21H2,1-4H3,(H,47,55)(H,43,44,46)(H,45,54,56)
InChIKeyWVXSCMCWBIBRNV-UHFFFAOYSA-N
MW829.87 g/mol
LogP2.00
Rot. Bonds9

About 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide

4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide (PubChem CID 167463013) has the molecular formula C40H45F2N11O7 and a molecular weight of 829.87 g/mol. Its IUPAC name is 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide.

Molecular Properties

Compound Name4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide
PubChem CID167463013
Molecular FormulaC40H45F2N11O7
Molecular Weight829.87 g/mol
Exact Mass829.35
IUPAC Name4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide
SMILESCOc1cc(C(=O)NN2CCC(N3CCN(c4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C2)ccc1Nc1ncc2c(n1)N(C(C)C)CC(F)(F)C(=O)N2C
InChIInChI=1S/C40H45F2N11O7/c1-22(2)52-21-40(41,42)38(59)48(3)29-19-43-39(46-33(29)52)44-26-9-8-23(18-30(26)60-4)34(55)47-51-13-12-24(20-51)49-14-16-50(17-15-49)27-7-5-6-25-32(27)37(58)53(36(25)57)28-10-11-31(54)45-35(28)56/h5-9,18-19,22,24,28H,10-17,20-21H2,1-4H3,(H,47,55)(H,43,44,46)(H,45,54,56)
InChIKeyWVXSCMCWBIBRNV-UHFFFAOYSA-N
XLogP2.00
TPSA192.96 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms60
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500829.87
LogP ≤ 52.00
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide?
The IUPAC name of 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide (CID 167463013) is 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide.
What is the SMILES notation for 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide?
The canonical SMILES for 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide is COc1cc(C(=O)NN2CCC(N3CCN(c4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C2)ccc1Nc1ncc2c(n1)N(C(C)C)CC(F)(F)C(=O)N2C.
What is the InChIKey of 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide?
The InChIKey is WVXSCMCWBIBRNV-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H45F2N11O7/c1-22(2)52-21-40(41,42)38(59)48(3)29-19-43-39(46-33(29)52)44-26-9-8-23(18-30(26)60-4)34(55)47-51-13-12-24(20-51)49-14-16-50(17-15-49)27-7-5-6-25-32(27)37(58)53(36(25)57)28-10-11-31(54)45-35(28)56/h5-9,18-19,22,24,28H,10-17,20-21H2,1-4H3,(H,47,55)(H,43,44,46)(H,45,54,56).
What are the key properties of 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide?
4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide has a molecular weight of 829.87 g/mol, XLogP of 2.00, 9 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-N-[3-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]piperazin-1-yl]pyrrolidin-1-yl]-3-methoxybenzamide is sourced from PubChem (CID 167463013), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).